Public Profile

GSH Bio-Technology

GSH Bio-Technology, also known as GSH Bio, is a leading player in the biotechnology industry, headquartered in China (CN). Founded in 2015, the company has rapidly established itself in the fields of health and wellness, focusing on innovative solutions that harness the power of natural compounds. With a strong emphasis on research and development, GSH Bio-Technology offers a range of unique products, including NMN (Nicotinamide Mononucleotide) supplements, which are designed to promote cellular health and longevity. The company’s commitment to quality and scientific integrity has positioned it as a trusted name in the market, catering to both domestic and international clients. GSH Bio's notable achievements include significant advancements in the formulation of its products, setting industry standards for efficacy and safety. As it continues to expand its operational reach, GSH Bio remains dedicated to enhancing the well-being of individuals worldwide.

DitchCarbon Score

How does GSH Bio-Technology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

GSH Bio-Technology's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

GSH Bio-Technology's reported carbon emissions

GSH Bio-Technology, headquartered in CN, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that GSH Bio-Technology may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it will be essential for GSH Bio-Technology to establish clear emissions reduction goals and commitments to align with global climate standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. GSH Bio-Technology's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. GSH Bio-Technology is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

GSH Bio-Technology is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

ArcticSource1

US
Health Services
Updated 11 days ago

Meilleure Health International Industry

HK
Health Services
Updated 10 days ago

BL Bio Lab

US
Health Services
Updated 11 days ago

Pacira BioSciences

US
Health Services
Updated 11 days ago

Apollo Hospitals

IN
Health Services
Updated 11 days ago

1Life Healthcare, Inc.

US
Health Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers